Xu et al. described a large series (n=75) of SOX11-negative MCL and reported that such subgroups have classic morphology, increased CD23 coexpression, lower proliferation rate, increased extranodal involvement, and more propensity for leukemic transformation compared to the SOX11-positive subgroup [20]. Here, SOX11 is linked to mantle cell lymphoma.